This review assesses the extent and the significance of catalytic versatility shown by several inositol phosphate kinases: the inositol phosphate multikinase, the reversible Ins(1,3,4)P 3 / Ins(3,4,5,6)P 4 kinase, and the kinases that synthesize diphosphoinositol polyphosphates. Particular emphasis is placed upon data that are relevant to the situation in vivo. It will be shown that catalytic promiscuity towards different inositol phosphates is not typically an evolutionary compromise, but instead is sometimes exploited to facilitate tight regulation of physiological processes. This multifunctionality can add to the complexity with which inositol signalling pathways interact. This review also assesses some proposed additional functions for the catalytic domains, including transcriptional regulation, protein kinase activity and control by molecular 'switching', all in the context of growing interest in 'moonlighting' (gene-sharing) proteins Ann. Med. 35, [28] [29] [30] [31] [32] [33] [34] [35] .
INTRODUCTION
A large number of molecules result from the ability of cells to place phosphate groups -and sometimes diphosphate groupsin combinatorial manner around the six-carbon myo-inositol ring. The multitudinous composition of this family challenges our efforts to understand the nature of the proteins that either metabolize the inositol phosphates or mediate their intracellular functions. For example, consider situations in which a biologically active inositol phosphate interacts with a target protein in a highly specific manner that excludes all other inositol phosphate isomers. What is the structural basis for this protein specificity? What are the ligand recognition motifs on the inositol phosphate? The same queries can also be posed for some of the enzymes that metabolize inositol phosphates, which, likewise, are highly specific. However, we should also ask about a contrasting situation: what is the structural basis for promiscuity among some of the enzymes that direct inositol phosphate turnover? We should also enquire into its biological relevance; while the significance to the cell of ligand specificity is self-evident, the importance of promiscuous catalytic activity towards several inositol phosphates is not always obvious. This problem can be complicated by a sometimes misleading range of catalytic activities that can be achieved by a single enzyme in vitro. This might come to light only when the experimenter is endowed with extensive quantities of both recombinant enzyme and patience. Such enzyme multifunctionality does not necessarily occur in intact cells. This is one of the issues that this review will address.
There are instances where diversity in enzyme function has been proposed to go beyond an ability to convert one inositol phosphate into another. Recently, one of the inositol kinases was reported also to have protein kinase activity, and another has been proposed to empower the activity of transcriptional control complexes. Are these 'moonlighting' activities [1] that are independent of the protein's 'day jobs'? Or do they provide a means to functionally couple inositol phosphate turnover to Abbreviations used: CaMKII, calmodulin-dependent protein kinase II; Crac, cytosolic regulator of adenylate cyclase; Ipmk, inositol phosphate multikinase; PTEN, phosphatase and tensin homologue deleted on chromosome 10; TNF, tumour necrosis factor. 1 e-mail shears@niehs.nih.gov other cell-signalling events? General examples of both optionsindependent and interdependent multifunctionality -do occur [2] . Interest in such versatility is growing as its structural, functional, evolutionary and therapeutic implications become more widely appreciated [2] [3] [4] . As we shall see, when a protein is genuinely pleiotropic, it can be difficult to establish the relative importance of each of its various activities to a physiological process. Nevertheless, it is the goal of this review to draw some conclusions as to just how multifaceted these inositol kinases can be.
INOSITOL PHOSPHATE DIVERSITY AND NOMENCLATURE
In order to appreciate the similarities and differences in the structures of the various inositol phosphates, it is necessary to understand the nomenclature upon which their description depends. Agranoff's 'turtle' [5] provides us with a useful, visual mnemonic. In this aide-memoire (Figure 1a ), the hydrogens are conveniently ignored and the inositol ring is depicted in its thermodynamically stable, so-called 'chair' conformation. The structure's resemblance to a turtle is then apparent (Figure 1b ). An International Nomenclature Committee [6] has stipulated that, when viewed from above, the turtle's appendages can be numbered in an anticlockwise direction commencing with the front right flipper (the D-stereochemical designation). The erect turtle's head represents the axial (i.e. perpendicular) orientation of the 2-hydroxy group relative to the plane of the ring, whereas the other five hydroxy groups (the four flippers and the tail) are equatorial (i.e. approximately in the same plane as the ring). This system permits a ready and unambiguous numbering of the various carbons around the inositol ring. Inositol 1,4,5-trisphosphate, for example, the well-known intracellular Ca 2+ -mobilizing signal [7] , has three single phosphate groups, at positions 1, 4 and 5. Ins(1,4,5)P 3 and (1,4,5)IP 3 are both widely accepted shorthand descriptions of this molecule (here, the 'P' is italicized to designate phosphate rather than phosphorus, but At physiological pH, inositol and its phosphorylated derivatives adopt a thermodynamically stable, staggered chair conformation, with one axial and five equatorial groups [150] , that has been said to resemble a turtle [5] most journals no longer make this distinction). As for the goal of unambiguously describing the enzymes that direct inositol phosphate turnover, when the activity is specific, it is quite simple: the enzyme that adds a 3-phosphate to Ins(1,4,5)P 3 is termed an 'Ins(1,4,5)P 3 3-kinase'. Unfortunately, but perhaps inevitably, enzymes that display a more complex catalytic repertoire are afflicted with a less systematic nomenclature (see below).
THE INOSITOL PHOSPHATE 'MULTIKINASE'
Ins(1,4,5)P 3 phosphorylation and the discovery of the 'multikinase ' The first family of inositol phosphate kinases to be discovered specifically phosphorylate the 3-position of Ins(1,4,5)P 3 , yielding Ins(1,3,4,5)P 4 [8, 9] ; no other naturally occurring inositol phosphates are substrates. Animal cells express three isoforms of this kinase family, which differ in their intracellular distribution and in the manner in which their catalytic activity is regulated [10] . Nevertheless, these particular enzymes are not themselves multifunctional. Their physiological role is only to phosphorylate Ins(1,4,5)P 3 to Ins(1,3,4,5)P 4 [10] . This reaction serves to control Ca 2+ mobilization [7, 11] , and provides precursor material for more highly phosphorylated inositol phosphates (Scheme 1). The latter anabolic pathway is usually near-saturated in non-stimulated cells, fed by an ongoing basal rate of Ins(1,4,5)P 3 synthesis and metabolism. Thus overexpression of the 3-kinase does not alter mass levels of Ins(1,3,4,5,6)P 5 and InsP 6 [12] .
A different enzyme, which phosphorylates Ins(1,4,5)P 3 at C-6, was discovered initially in peas [13] and detected subsequently in Saccharomyces cerevisiae [14] and Schizosaccharomyces pombe [15] . This enzyme received relatively little attention, however, until it was cloned from Sacch. cerevisiae by two groups working independently [16, 17] . It was thereby revealed that this protein already had a 20-year history as a transcriptional regulator [18] [19] [20] [21] [22] ; in that context it was known as Arg82 (and the nom de guerre ArgRIII). Odom et al. [17] re-christened this protein 'Ipk2', Shown are the quantitatively most important routes of Ins(1,4,5)P 3 phosphorylation in vivo, based on data from several publications that are discussed in the text. Interestingly, even though the yeast and mammalian forms of Ipmk (inositol phosphate multikinase) contribute different catalytic activities to dissimilar metabolic pathways, in each case this enzyme is essential to the cells' major pathway of Ins(1,3,4,5,6)P 5 synthesis de novo. In contrast, plants and slime moulds can synthesize Ins(1,3,4,5,6)P 5 and InsP 6 by alternative pathways that are independent of Ins(1,4,5)P 3 [102, 103] . However, it is not the role of this Scheme to show all inositol phosphate interconversions (for a more complete picture, see [11] for example). It is assumed that the failure to detect Ins(1,4,5)P 3 3-kinases in plants [11] while Snyder's group [16] preferred 'Ipmk (inositol phosphate multikinase)'. The use of Ipmk is frowned upon in the yeast field, where abbreviations with no more than three letters are de rigeur. However, in the opinion of the author, Ipmk is the most descriptive of this protein's aliases, and so this abbreviation is used here for clarity.
Homologues of Ipmk are present in animal and plant cells (Figure 2 ; [23] [24] [25] [26] ). Each of these isoforms has conserved catalytic residues (Figure 2) . A transcriptionally active poly(Asp)
Figure 2 Domain organization of Ipmk in humans, yeasts and a plant
The Figure depicts a schematic alignment of Ipmk homologues from Arabidopsis thaliana (At, type α; GenBank AY147935), Schizosaccharomyces pombe (Sp; CAB63791), Saccharomyces cerevisiae (Sc; CAA28945 as ArgRIII) and Homo sapiens (Hs; AAM97838) and a putative homologue from Aspergillus nidulans (An; accession number AN0156; http://wwwgenome.wi.mit.edu/annotation/fungi/aspergillus). Note that the predicted molecular mass of Schizosaccharomyces pombe Ipmk (30 kDa) is different from the estimated size of the purified protein (41 kDa [15] ). Numbers above arrows depict amino acid residues but, for clarity, scaling is approximate. The catalytic InsP-binding consensus sequence (PxxxDxKxG; in blue) was first noted in [17] and [16] ; York's group [17] were the first to confirm this with mutagenic studies. A putative ATP-binding site (
in yellow) was first identified by Saiardi et al. [25] in mammalian Ipmk. The nuclear localization signal (NLS; in green) was characterized by Mayr and colleagues [23] . The alignment of Ipmk from A. thaliana was previously described by York's group [26] . The SSLL-like motif is also conserved in InsP 6 kinases, where it has been shown to be necessary for catalysis [25, 61] . The poly(Asp) region ([D] 17 ; in red) is required in Sacch. cerevisiae Ipmk for transcriptional control over arginine-regulated genes [19] . The putative Aspergillus nidulans Ipmk has two acidic domains (poly[Asp/Glu]); perhaps not coincidentally, the mechanism by which arginine induces the ornithine transaminase gene in Aspergillus nidulans shows similarities to the process in Sacch. cerevisiae [153] . A W65R mutant in Sacch. cerevisiae Ipmk compromises both transcriptional control [19] and inositol phosphate kinase activity in vivo [61] . Human Ipmk has 84 % sequence identity with rat Ipmk, 25 % identity with Arabidopsis thaliana Ipmk, 20 % identity with Aspergillus nidulans Ipmk, and 16 % identity with Sacch. cerevisiae Ipmk ( [24, 26] , and results not shown).
acidic domain [19] has a more restricted occurrence, and is so far known to be present only in Sacch. cerevisiae, with possibly a potential homologue in Aspergillus nidulans (Figure 2 ). Ipmk is more widely distributed in Nature than is the Ins(1,4,5)P 3 3-kinase family, which is apparently restricted to the animal kingdom [11] . In fact, a primordial Ipmk may have been the evolutionary precursor of the 3-kinases [11, 16, 17] and the InsP 6 kinases [27] , all of which contain the PxxxDxKxG catalytic domain. The human IPMK gene contains six exons and is located on chromosome 10 [23] . The mRNA transcript is expressed ubiquitously; in humans there are particularly high levels of expression in liver and skeletal muscle [24] , whereas in the rat the highest levels of expression were observed in kidney and brain [25] . Northern analysis suggests there is alternative splicing of mRNA transcripts for Ipmk [24, 25] . The significance of there being multiple mRNAs is typically interpreted in terms of their differing in either stability or translatability, in order to modulate gene expression in a tissue-or developmental-stagespecific manner [28] .
How many inositol phosphate kinase reactions are catalysed by Ipmk?
Recombinant yeast and plant Ipmks phosphorylate Ins(1,4,5)P 3 mainly to Ins(1,4,5,6)P 4 [17, 26, 29] . The Ins(1,4,5,6)P 4 is phosphorylated further by Ipmk at the 3-position, yielding Ins(1,3,4,5,6)P 5 and InsP 6 can both be phosphorylated in an ATP-dependent manner by the 'InsP 6 kinase' (EC 2.7.4.21), which is known as Kcs1 in yeast. Hydrolysis of diphosphoinositol polyphosphates is catalysed by specific phosphohydrolases [133, 137] . The Figure shows the diphosphate group in PP-InsP 5 attached to C-5, which is known to be the case in animal cells [154] ; the same is assumed for PP-InsP 4 . Some 5-PP-InsP 5 is also present in slime moulds such as Dictyostelium [154] , but the 6-PP-InsP 5 isomer predominates in these organisms [139, 154] . See also Figure 6 .
Ins(1,3,4,5,6)P 5 [17, 29] . The yeast enzyme will also form some Ins(1,3,4,5)P 4 from Ins(1,4,5)P 3 [29] , but studies with intact cells show that this is not a major pathway in vivo [17, 29] . This assessment of the major route of Ins(1,4,5)P 3 phosphorylation in yeasts and plants is summarized in Scheme 1. Recombinant mammalian Ipmk displays a different positional specificity towards Ins(1,4,5)P 3 , phosphorylating it primarily to Ins(1,3,4,5)P 4 [23, 25] , although kinetic data indicate that this reaction has little significance in vivo (see below). There are also some as yet unpublished results that indicate that the 3-kinase activity of Ipmk phosphorylates PtdIns(4,5)P 2 to PtdIns(3,4,5)P 3 (A. Resnick, A. Saiardi and S. H. Snyder, personal communication). The possibility that Ipmk might synthesize PtdIns(3,4,5)P 3 represents a tantalizing potential addition to this enzyme's versatility.
Recombinant mammalian Ipmk can phosphorylate Ins(4,5)P 2 in vitro [25] . This is unlikely to be a significant reaction in vivo, where little Ins(4,5)P 2 is generally seen, except in neuronal cells treated with millimolar concentrations of lithium [30, 31] , which is an experimental protocol designed to mimic the therapeutic application of this cation as an anti-manic agent. In any case, Ins(4,5)P 2 does not compete well with Ins(1,4,5)P 3 [25] , which itself is probably not the optimum substrate in vivo (see below). Another reaction catalysed by Ipmk in vivo is the phosphorylation of Ins(1,3,4,5,6)P 5 to PP-InsP 4 , a diphosphorylated ( Figure 3 ) inositol phosphate [25, 27] . {The last two studies corrected an erroneous suggestion [16] that InsP 6 was the product of phosphorylation of Ins(1,3,4,5,6)P 5 by Ipmk.} However, PPInsP 4 synthesis from Ins(1,3,4,5,6)P 5 appears too slow to be of much physiological significance [23, 25, 27] .
The above discussion illustrates that Ipmk can perform reactions in vitro that seem not to be relevant in vivo. This point emphasizes the value of verifying Ipmk catalytic activities by manipulating the levels of expression of the enzyme in intact cells. Since ipmk strains of Sacch. cerevisiae are viable (in a nitrogenrich medium), the impact of the gene deletion upon steady-state levels of inositol phosphates can be determined [17, 29, 32] . In these experiments, intact cells were incubated with [ 3 H]inositol so as to radiolabel the phosphate pools, the sizes of which were then determined by separating the constituents of cell lysates using HPLC. The severity of the impediment to Ins(1,4,5)P 3 phosphorylation in ipmk cells was disclosed by the 170-fold elevation in the cellular levels of [ 3 H]Ins(1,4,5)P 3 , compared with wild-type cells [17, 29] . The steady-state levels of Ins(1,3,4,5,6)P 5 , the end-product of Ipmk activity (Scheme 1), were also reduced by approx. 90 % in ipmk cells [29] . More strikingly, the normally high level of InsP 6 was reduced > 100-fold in the ipmk cells [17, 29] . Thus Ipmk is virtually indispensable for the synthesis of InsP 6 in yeast (Scheme 1).
Studies with a human [24] and a plant [26] Ipmk recently indicated a very important addition to the enzyme's versatility, with the demonstration that it is also an Ins(1,3,4,6)P 4 5-kinase. Kinetic data obtained with recombinant human Ipmk in Majerus' laboratory argue strongly that the Ins(1,3,4,6)P 4 5-kinase reaction is actually more physiologically active than its Ins(1,4,5)P 3 3-kinase activity [24] . There is another reason for believing that Ipmk does not normally provide a quantitatively important pathway of Ins(1,4,5)P 3 phosphorylation in vivo: the catalytic efficiency of this reaction is considerably lower than that achieved by the dedicated Ins(1,4,5)P 3 3-kinases [24] . Of course, these arguments are not irrefutable. There is always the possibility that some of the cellular Ins(1,4,5)P 3 is in a metabolic compartment, possibly at a locally elevated concentration, with privileged access to Ipmk. Actually, there are some older studies that concluded that Ins(1,4,5)P 3 can be compartmentalized [33, 34] , but the inability to define the nature of the phenomenon (e.g. [35] ) has contributed to a lack of current interest in this topic.
Mammalian Ipmk also has Ins(1,4,5,6)P 4 3-kinase activity [24] that may be important. This seems likely to account for the Ins(1,4,5,6)P 4 3-kinase activity that was observed in cell lysates in earlier experiments performed in our laboratory [36, 37] . This 3-kinase activity was competitively inhibited by Ins(1,3,4,6)P 4 [37] , which we now appreciate is consistent with what we should expect from Ipmk (it is unclear if this competition has any physiological significance). Other evidence that Ins(1,4,5,6)P 4 3-kinase is an ongoing reaction in intact cells comes from experiments in which the kinase was inhibited by reducing the levels of ATP, whereupon the concentration of Ins(1,4,5,6)P 4 increased [36] . The source of that Ins(1,4,5,6)P 4 is Ins(1,3,4,5,6)P 5 [36] . That is, there appears to be an ongoing 3-phosphatase/3-kinase substrate cycle between Ins(1,3,4,5,6)P 5 and Ins(1,4,5,6)P 4 (Scheme 1). Thus the lack of general recognition given to the extent of cellular Ins(1,4,5,6)P 4 3-kinase activity reflects an under-appreciation of the catalytic versatility of Ipmk in vivo.
There are several reasons why it might prove productive to study this Ins(1,3,4,5,6)P 5 3-phosphatase/Ins(1,4,5,6)P 4 3-kinase cycle further. The cycle appears to be grossly perturbed by the SopE invasion factor from Salmonella typhimurium, leading to a rapid and catastrophic net dephosphorylation of Ins(1,3,4,5,6)P 5 to Ins(1,4,5,6)P 4 [38] . Since SopE cannot itself dephosphorylate Ins(1,3,4,5,6)P 5 , it must act by hijacking the host cell's Ins(1,3,4,5,6)P 5 phosphatase and/or inhibiting the Ins(1,4,5,6)P 4 3-kinase [38] . It will be interesting to determine whether this effect of SopE represents an example of structural mimicry, by which pathogen virulence factors have evolved to imitate -and often to exaggerate -the activities of the host cell's proteins [39] . As for the nature of the Ins(1,3,4,5,6)P 5 3-phosphatase, there is a very well characterized and highly active enzyme with this activity (multiple inositol-polyphosphate phosphatase; Scheme 1), but that is trapped inside the lumen of the endoplasmic reticulum, with apparently restricted access to inositol phosphates [40] [41] [42] [43] . More recently, we demonstrated that PTEN ('phosphatase and tensin homologue deleted on chromosome 10'), classically recognized to be an inositol lipid 3-phosphatase [44, 45] , is actually in addition an efficient Ins(1,3,4,5,6)P 5 3-phosphatase, both in vitro and in vivo [46] . This reactivity towards Ins(1,3,4,5,6)P 5 is likely to be insignificant when PTEN is membrane-associated, whereupon the catalytic activity towards PtdIns(3,4,5)P 3 (but not inositol phosphates) undergoes considerable interfacial activation by anionic inositol lipids [47] . However, a substantial proportion of endogenous PTEN is not actually bound to membranes [48] and is instead in the cytosol and the nucleus, and it is under these conditions that it can have ready access to the relatively large (15-50 µM) cellular pool of Ins(1,3,4,5,6)P 5 . PTEN is unlikely to hydrolyse other inositol phosphates in vivo; InsP 6 , Ins(1,4,5,6)P 4 and Ins(1,4,5)P 3 are not substrates [45, 46] , and both Ins(1,3,4,5)P 4 and Ins(1,3,4)P 3 are very poor substrates in vitro [45] [46] [47] . Perhaps Ins(1,3,4,5,6)P 5 is a specific, regulatable metabolic 'clamp' that impedes access of PTEN to PtdIns(3,4,5)P 3 [46, 49] . Moreover, Ins(1,3,4,5,6)P 5 would appear to present a substantial impediment to PTEN's already limited capacity to also use its catalytic site to dephosphorylate proteins [45] . In any case, PTEN and Ipmk represent the best candidates for the enzymes that participate in the ongoing metabolic cycling between Ins(1,4,5,6)P 4 and Ins(1,3,4,5,6)P 5 [36] . It is possible that this ongoing cycle merely represents a metabolic cost of using Ins(1,3,4,5,6)P 5 to regulate PTEN activity towards PtdIns(3,4,5)P 3 . Alternatively, the inositol phosphate cycle might be independently functional.
Rationalization of the different inositol phosphate kinase reactions catalysed by Ipmk
The ability of Ipmk to phosphorylate both InsP 3 and InsP 4 is lost upon substitution of Asp-131 by Ala [17] . This result is consistent with there being a single active site on this protein. One reaction mechanism that has been advocated [24] is that the Ins(1,4,5)P 3 substrate is held at the active site while the two phosphate groups are added, in either a stepwise or a concerted manner. However, an observation that argues against this idea is that the InsP 4 intermediate is released into the bulk phase and accumulates (see above).
Moreover, it is necessary to account for the ability of Ipmk to add a phosphate group to various inositol phosphates at differing positions around the inositol ring (see above). Well-evolved enzymes do not typically indulge in haphazard regiochemistry [4] , so instead one should consider whether the catalytic specificity can be maintained by presenting key substrate recognition features to the active site in alternative binding orientations or 'modes' [50] . This idea has previously helped to account for the catalytic versatility of native Ipmk that was partially purified from Schiz. pombe [15] . This model (summarized in Figure 4 ) proposes that Ipmk can accommodate its different substrates in three binding modes. In each of these modes, three recognition elements are presented to Ipmk that are common both in nature and in orientation around the inositol ring: two phosphates and the hydroxy group that is phosphorylated (coloured red in Figure 4 ). These groups are likely to be essential for substrate recognition. Two binding modes for Ins(1,4,5)P 3 are suggested, in order to account for its phosphorylation at both the 3-and 6-positions. Presumably, yeast Ipmk has a higher affinity for Ins(1,4,5)P 3 in mode 2, as the enzyme mainly phosphorylates Ins(1,4,5)P 3 to Ins(1,4,5,6)P 4 [17, 29] . Conversely, mammalian Ipmk is suggested to prefer to bind Ins(1,4,5)P 3 in mode 1, since it phosphorylates Ins(1,4,5)P 3 largely to Ins(1,3,4,5)P 4 [23, 24] . The ability of the enzyme to phosphorylate Ins(1,4,5,6)P 4 and Ins(1,3,4,5)P 4 is also nicely accommodated by this model (Figure 4 ). The 1998 study with Ipmk isolated from Schiz. pombe also predicted a
Figure 4 Proposed combinatorial recognition motifs for Ipmk
The diagram shows three proposed substrate-binding modes utilized by Ipmk, as originally proposed in [15] . Note where the inositol ring has been rotated through vertical and/or horizontal planes in order to align equivalent recognition motifs. The site of phosphorylation is indicated by a yellow circle. Groups that are coloured red are common to all three binding modes and are proposed to be essential for high-affinity ligand recognition, but they are clearly insufficient (see the text). It is therefore proposed here that certain groups define substrate recognition in a mode-specific manner. Groups coloured purple, that are common to two binding modes, are considered most likely to play this role. Groups coloured green are deemed least important to substrate recognition, as their position is common to only one binding mode. Note that Ins(1,4,5)P 3 is proposed to bind to yeast Ipmk preferentially in mode 2, whereas mammalian Ipmk prefers mode 1 (see the text for details).
third binding mode that could accommodate Ins(1,4,6)P 3 and facilitate its phosphorylation at the 5-position [15] . At that time, the physiological relevance of this observation was unknown, since Ins(1,4,6)P 3 is not a significant constituent of the inositol phosphate metabolic pathway. Figure 4 now argues that the importance of the third binding mode is for the Ins(1,3,4,6)P 4 5-kinase activity of Ipmk, a key anabolic reaction in animal and plant cells (Scheme 1).
It was recognized previously that the three substituents on the inositol ring (coloured red in Figure 4 ) that are common to each binding mode are insufficient to define ligand specificity, since all three groups are present on Ins(1,4)P 2 , which is not a substrate [15] . Attempts to rationalize the contributions made by other groups around the inositol ring were previously confounded by the belief that the enzyme also phosphorylated Ins(1,3,4,5,6)P 5 to InsP 6 [15] . However, we now know that the Ins(1,3,4,5,6)P 5 2-kinase is a separate enzyme [51] that must have contaminated the earlier [15] preparations of native Ipmk. It is therefore proposed here that substrate recognition occurs in a combinatorial manner. That is, mandatory substrate recognition features (coloured red in Figure 4 ) are proposed to act in concert with certain other groups that define substrate recognition in a mode-specific manner. Note that there are groups on the inositol ring that are conserved in terms of composition and orientation in two binding modes (coloured purple in Figure 4 ). By virtue of this conservation, they are deemed most likely to participate in mode-specific ligand recognition. Each of the remaining substituents, which are not conserved between binding modes (coloured green in Figure 4 ), are considered less likely to define substrate recognition, although a possible contribution cannot be excluded. This model for ligand binding suggests that Ipmk might be one of those proteins [4] that utilizes rigid and flexible regions in its active site. The more constrained amino acid residues could sustain specific interactions with the mandatory substrate recognition features, whereas the more flexible regions of the protein would have the adaptability to contribute to mode-specific interactions. This hypothesis raises the possibility that a mutation in a flexible amino acid residue that participates in mode-specific binding might only compromise ligand recognition in that particular mode. Perhaps such a phenomenon underlies the nature of an Ipmk mutant, named 2-3 [17] , in which Ins(1,4,5,6)P 4 3-kinase activity (i.e. mode 1) is defective, even though Ins(1,4,5)P 3 6-kinase activity (i.e. mode 2) is intact (see also [24] ). All of these ideas can be examined more closely when the structure of Ipmk is solved.
Ipmk and transcription: arginine-regulated genes in yeast
As mentioned above, before Ipmk was established to be an inositol phosphate kinase, the yeast protein had accumulated a 20-year history as a transcriptional regulator, acting under its Arg82 alias. In this guise, Arg82 has become well known to participate in the process by which Sacch. cerevisiae prioritizes its use of alternative nitrogen sources. In the presence of arginine or ornithine, three proteins (named Arg80, Arg81 and Mcm1) assemble into a transcriptional complex (ArgR-Mcm1) which binds to the regulatory elements of several co-regulated genes that encode enzymes involved in arginine metabolism [20] . As a consequence, two enzymes which catabolize arginine and ornithine are induced (the CAR1 and CAR2 gene products respectively) and several enzymes of arginine synthesis are repressed (the ARG1, ARG3, ARG5,6 and ARG8 gene products). These transcriptional control processes also require Ipmk [52] . Until recently, it was generally thought that Ipmk is not a necessary constituent of the DNA-bound transcriptional complex [19, 21, 53, 54] . Instead, it was argued that Ipmk acts at an earlier stage, by stabilizing Mcm1 and Arg80, and also by facilitating their assembly into a multimeric complex [21, 53, 54] . Apparently critical to this process is a poly(Asp)-rich acidic domain between amino acid residues 282 and 303 near the C-terminus of Ipmk (Figure 2 ). Evidence in support of this idea includes the observation [54] that the stability of Mcm1 and Arg80 after cycloheximide treatment is impaired in the ipmk /ipmk 282−303 strain (i.e ipmk cells transformed with a plasmid encoding ipmk 282−303 ). Two-hybrid assays indicated that the interaction between Arg80 and Mcm1 is also disrupted in the ipmk /ipmk 282−303 strain [54] . The absence of this acidic domain from the Ipmk from Schiz. pombe (Figure 2 ) appears to explain why it fails to rescue the defective regulation of arginine-sensitive genes in the ipmk strain of Sacch. cerevisiae [54] .
A paper by Odom et al. [17] offers a dramatic expansion in the versatility of Ipmk (which in their paper was named Ipk2; see above). It is important to note that this new model does not refute any of the earlier work showing that Ipmk is required to assemble the ArgR-Mcm1 complex (see above). This new hypothesis argues that, in addition to the kinase-independent mechanisms described above, the kinase catalytic domain of Ipmk is proposed to be ". . . required to properly execute transcriptional control as measured by growth on ornithine as the sole nitrogen source". For cells to survive and grow on such medium, ornithine has to induce the expression of the CAR2 gene product, ornithine transaminase; this process requires a functional ArgR-Mcm1 transcriptional complex [55, 56] . When cells are grown on nitrogen-rich media, the requirement for CAR2 induction is bypassed. Therefore a defect in Ipmk that impairs ArgR-Mcm1 function might reveal itself as a growth-impaired phenotype that is specific to ornithine being offered as the sole nitrogen source. In their study, Odom et al. [17] transformed ipmk cells with an ipmk D131A plasmid (which encodes a 'kinase-dead' mutant). When plated on an ornithine-based medium, the rate of growth of the ipmk /ipmk D131A cells was reduced relative to growth of the wild-type strain [17] . This result led to the proposal [17] that the kinase activity of Ipmk is necessary for the ArgR-Mcm1 transcriptional complex to induce CAR2 expression. However, this interpretation has been disputed by others [32] , who have reported that the growth defect exhibited by ipmk /ipmk D131A cells was not nutritionally dependent, and instead was general in nature, since, in their hands, it was observed irrespective of whether ornithine, ammonia or glutamate was offered as the sole nitrogen source ( [32] ; E. Dubois and F. Messenguy, personal communication). Moreover, measurements of the cellular levels of arginase (the CAR1 gene product) did not indicate that expression of that particular gene was controlled by the kinase activity of Ipmk [32] . One way to move forward on this difference of opinion concerning the extent to which Ipmk kinase drives CAR2 expression might be for its proponents to assay the induction of the CAR2 promoter-lacZ fusion reporter construct described previously [57] . Incidentally, it should be noted that there is agreement that the repression of the So as not to base their hypothesis entirely upon cell growth data, Odom et al. [17] also studied the role of Ipmk by monitoring plating efficiency, which describes the proportion of dispersed single cells that divide and form colonies; this essentially measures cell viability [58] . In an ornithine-based medium, the ipmk and ipmk /ipmk D131A strains showed < 2 % plating efficiency [17] . This almost complete lack of cell viability was blamed on their inability to obtain nitrogen from the ornithine; that is, the CAR2 gene product which converts ornithine into glutamate was proposed not to be induced. However, when glutamate is offered as an alternative nitrogen source, the need for CAR2 induction is bypassed. Both ipmk and ipmk /ipmk D131A strains were reported to show near-normal cell viability when glutamate replaced ornithine as the sole nitrogen source ( [17] ; J. D. York, personal communication). Thus it was proposed that the inositol kinase activity of Ipmk was necessary for CAR2 gene induction.
Unfortunately, the quantification of plating efficiency is not always an exact science. There are a number of factors that can introduce variability [58] . For example, the results that are obtained can be influenced by the methods used to disperse the original cells [58] . In addition, individual viable cells may vary greatly in the lag time before discernable growth and division can be observed. Thus it may be difficult to know how long one should observe a cell before pronouncing it non-viable [58] . Even plate age and moisture content have been suggested to affect the results (J. D. York, personal communication). Some variability between experiments is therefore to be expected. Indeed, the plating efficiency of the ipmk /ipmk D131A strain grown on ornithine (calculated relative to that of cells grown on nitrogen-rich media), originally reported to be < 2 % This worrisome variability advises us to assess the data cautiously. A nutritionally dependent contribution to the reduced cell viability of the ipmk /ipmk D131A strain was observed by E. Dubois and F. Messenguy (personal communication) . That is, the number of surviving ipmk /ipmk D131A cells increased when they were offered a nitrogen source (e.g. glutamate) that was more 'userfriendly' than ornithine, although this was a much smaller effect than that reported by Odom et al. [17] . These data should also be interpreted with care, since even wild-type cells exhibit improved cell viability when grown on glutamate or ammonia, compared with poorer-quality nitrogen sources such as ornithine or proline (E. Dubois and F. Messenguy, personal communication).
Odom et al. [17] also transformed ipmk cells with the Ipmk mutant named 2-3 (see above). These cells phosphorylate Ins(1,4,5)P 3 to Ins(1,4,5,6)P 4 , but cannot phosphorylate Ins(1,4,5,6)P 4 further (see also [24] ). The plating efficiency of the ipmk /ipmk 2−3 strain was indistinguishable from that of wildtype cells, irrespective of the nitrogen source [17] . In other words, both ArgR-Mcm1 function and cell viability were reported to be normal in the absence of any inositol phosphates more highly phosphorylated than Ins(1,4,5,6)P 4 . This observation indicates that Ins(1,3,4,5,6)P 5 and InsP 6 are not responsible for any defects that arise when the kinase activity of Ipmk is mutated, but one aspect of this finding is arguably a little puzzling. The absence of InsP 6 would, from other studies, be expected to impair mRNA export from the nucleus [29, 59] , cause vacuolar fragmentation [60, 61] , compromise endocytosis [62] and impair cell wall integrity [61] ; it would not have been surprising if any one of these defects had impaired the viability of the ipmk /ipmk 2−3 strain to a certain extent.
Despite all of these difficulties, this idea that the kinase activity of Ipmk drives transcription [17] has been a very influential hypothesis (see below). It has been theorized that transcriptionally dormant ArgR-Mcm1 complexes might be silently poised on DNA regulatory elements, awaiting activation by the kinase activity of Ipmk [17, 63] . This idea dovetails nicely with an emerging hypothesis that certain inducible or repressible promoters may recruit regulatory enzymes that are maintained in an inactive state, until they are awakened by an appropriate stimulus [64] . Abrupt changes in the levels of signalling molecules such as inositol phosphates, with a concomitant activation of inositol phosphate kinase activity, provides an attractive model for rapid stimulation of the transcriptional process [64] . Messenguy et al. [20] have identified the ArgR-McM1 binding sites in the inducer elements of the CAR2 gene. As yet, there no evidence that a transcriptionally silent version of the ArgR-Mcm1complex can actually bind to this promoter.
Ipmk and transcription: phosphate-responsive genes in yeast
Transcription of PHO5, the gene encoding a secreted phosphatase, is regulated in response to phosphate availability by the reversible phosphorylation of Pho4 [65] . During conditions of phosphate starvation, Pho4 is activated by dephosphorylation, and then binds to the PHO5 promoter, and the phosphatase is expressed [66] . There was a dramatic reduction in the starvation-dependent induction of PHO5 mRNA levels in cells lacking the inositol kinase activity of Ipmk, most notably in ipmk /ipmk D131A cells [67] . One of the key new developments in this particular study is that, by recording PHO5 mRNA levels, the authors performed a more direct analysis of the effect of Ipmk upon transcription than can be obtained by measuring cell growth and viability.
Research into PHO5 is particularly significant because it has become a paradigm for understanding the relationship between transcription and the structure of DNA-protein complexes (i.e. chromatin) [68] . Chromatin undergoes transitions between closed, repressive states and remodelled, transcriptionally permissive states. Molecular mechanisms that switch between these two states lie at the very heart of eukaryotic gene regulation. O'Shea and colleagues [67] measured the accessibility of a ClaI restriction site in the PHO5 promoter in isolated nuclei when wild-type cells were shifted to PHO5-inducing conditions. This increased ClaI accessibility was impaired in ipmk /ipmk D131A cells [67] . In this way, the kinase activity of Ipmk was shown to be important for chromatin remodelling. Another key experiment was the demonstration, using chromatin immunoprecipitation, that the amount of Pho4 bound to the PHO5 promoter was considerably reduced in the ipmk strain [67] . This appeared to reflect defective operation of the SWI/SNF and INO80 chromatin remodelling complexes. These data have reinforced the concept [17] that the kinase activity of Ipmk has the functional versatility to regulate transcription. Moreover, mammalian cells contain homologues of Ipmk (see above) and SWI/SNF transcriptional complexes [69] , so chromatin remodelling is now receiving attention as possibly being a widespread action of Ipmk.
O'Shea and colleagues [67] recognized the possibility that loss of Ipmk catalytic activity could have affected cell functions indirectly, by depleting higher inositol phosphates (Scheme 1). They therefore studied control of PHO5 expression in two mutant yeast strains. In one of these, the Ins(1,3,4,5,6)P 5 kinase (Ipk1) was deleted so that cells could not synthesize InsP 6 . In the other strain, the InsP 6 kinase (Kcs1) was deleted and cells could not make diphosphoinositol polyphosphates. There was a slight decrease in PHO5 mRNA levels in both the ipk1 and kcs1 strains, suggesting an element of functional redundancy, but this effect was much less pronounced than in the ipmk cells [67] . Thus the major effect of Ipmk upon chromatin remodelling does appear to represent a direct effect of its own kinase activity.
Is the effect of the kinase activity of Ipmk on PHO5 transcription completely independent of the separate transcriptionally active acidic domain in the Ipmk from Sacch. cerevisiae [54] , and possibly also Aspergillus nidulans (Scheme 1)? There are certainly other examples of functionally separate domains within a single protein acting in an independent manner [2, 4] . However, deletion of the poly(Asp) domain in Ipmk from Sacch. cerevisiae reduced InsP 6 levels in vivo by approx. 25 % [61] . This suggests some, albeit limited, link between the function of this acidic domain and the control of inositol phosphate turnover. Alternatively, the ipmk 282−303 protein might have a modified tertiary structure that has non-specific consequences for the activity of the kinase domain.
Some cautionary notes may still be warranted. There are farreaching effects upon many mRNA species in yeast strains in which the catalytic activity of Ipmk is compromised [54] , and it will be important to separate primary regulatory events from secondary consequences. Secondly, metabolic homoeostasis utilizes regulatory processes that control the expression of genes encoding metabolic enzymes. Thus, as McKnight [70] recently reminded us, there are many links between gene regulation and metabolic status. It might be considered inevitable that control over phosphate supply to yeast, and the regulation of PHO5 expression, must be intertwined with regulation of inositol phosphate synthesis, which of course is a phosphate-consuming process. The big question, therefore, is whether this apparent effect of Ipmk upon chromatin remodelling reflects a rather mundane metabolic control process, or instead is this really part of a wider conspiracy that utilizes inositol phosphate turnover to control gene expression? Answers to these questions may come from efforts to determine whether or not the catalytic domain of Impk regulates transcription in other organisms. Given that advances in organism complexity walk hand-in-hand with increased sophistication of transcriptional control processes [71] , there are no guarantees that Ipmk has been retained throughout evolution as an important regulator of gene expression. Hopefully, future work on the role of Ipmk in higher eukaryotes will address these issues.
Towards understanding the mechanism by which the inositol kinase activity of Ipmk might regulate transcription: direct roles for inositol phosphates?
To address directly the extent of versatility of the kinase activity of Ipmk, it must be asked whether its postulated transcriptional effects are intrinsic to the catalytic domain of the protein, or are instead promoted in a secondary manner by the inositol phosphates themselves. A recent study is relevant to this question; that report indicated that certain inositol phosphates can remodel chromatin in vitro [72] . InsP 6 provided the main focus for this work, but it is a different and more minor part of the studythe effects of Ins(1,4,5,6)P 4 and Ins(1,3,4,5,6)P 5 -that has garnered the most attention [64, 67] . It was suggested that the effects of Ipmk upon PHO5 expression are due to direct stimulation of 'nucleosome sliding' by Ins(1,4,5,6)P 4 and Ins(1,3,4,5,6)P 5 [67, 72] . Nucleosomes are the basic repetitive unit of chromatin: histone octomers around which is wrapped approx. 150 bp of DNA [73] . Regulatory elements can be exposed when nucleosomes are nudged along the DNA helix by ATP-consuming nucleosome remodelling factors. Wu and colleagues [72] studied nucleosome movement along a Drosophila hsp70 DNA fragment driven by the yeast SWI/SNF chromatin remodelling complex. It was reported that 500 µM Ins(1,4,5,6)P 4 or Ins(1,3,4,5,6)P 5 stimulated this nucleosome sliding [72] . Lower concentrations have also been studied, but the effects were quite small. For example, 100 µM Ins(1,4,5,6)P 4 elicited only a 12% effect, and 50 µM was ineffective (C. Wu, personal communication). How do these concentrations compare with the levels of Ins(1,4,5,6)P 4 [29] . Cellular levels of InsP 6 in yeasts are approx. 40 µM [74] . This leads us to conclude that total cellular Ins(1,4,5,6)P 4 levels in yeast will not exceed 0.3 µM; the corresponding value for Ins(1,3,4,5,6)P 5 is 1 µM. Thus Wu and colleagues [72] studied the effects of inositol phosphates at concentrations that are 500-1700 times higher than estimated cellular levels. In such circumstances, it is difficult to accept that these effects are physiologically relevant.
Wu and colleagues [72] argued that compartmentalization of Ins(1,4,5,6)P 4 in the nucleus might elevate its levels locally. To what extent might this be possible? The nucleus is where most (although not all) of the cells' Ipmk is located [23, 75] . However, if we assume Ins(1,4,5,6)P 4 cannot escape the nucleus [even though Ins(1,4,5)P 3 must get in], and further assuming the yeast nucleus comprises 10 % of the total cell volume, then the nucleus could not concentrate Ins(1,4,5,6)P 4 more than 10-fold above its average cellular level of < 0.3 µM. This theoretical maximum concentration of 3 µM is still 30-fold less than a concentration of Ins(1,4,5,6)P 4 that only affected nucleosome sliding to a very marginal extent (12 %; see above). In any case, there is also a fundamental kinetic constraint that will prevent the accumulation of locally elevated levels of Ins(1,4,5,6)P 4 ; even low micromolar Ins(1,4,5,6)P 4 levels will discourage its own synthesis, by virtue of it being an alternative substrate of Ipmk (see above) that will competitively inhibit Ins(1,4,5)P 3 phosphorylation. As for Ins(1,3,4,5,6)P 5 , the end product of Ipmk activity, it is freely dispersed around the cytosol, at least in human cells [35] . Thus the study by Wu and colleagues [72] does not provide sufficient evidence that Ins(1,4,5,6)P 4 or Ins(1,3,4,5,6)P 5 can modulate chromatin remodelling in vivo. Finally, if it turns out that Ipmk is also an active PtdIns(4,5)P 2 3-kinase, as unpublished work suggests (A. Resnick, A. Saiardi and S. H. Snyder, personal communication), PtdIns(3,4,5)P 3 might then become an alternative candidate for regulating chromatin remodelling.
INS(1,3,4)P 3 /INS(3,4,5,6)P 4 KINASE

Discovery
The enzyme activity that phosphorylates Ins(1,3,4)P 3 to Ins(1,3,4,6)P 4 was discovered in 1987 by two groups working independently [76, 77] . At about the same time, a third group [78] discovered another enzyme activity that phosphorylates Ins(3,4,5,6)P 4 to Ins(1,3,4,5,6)P 5 . [In the latter paper, DIns(3,4,5,6)P 4 is named L-Ins(1,4,5,6)P 4 . The use of the 'L'-stereochemical designation was perfectly logical and appropriate, but these days it is considered more convenient to use the 'D' designation exclusively -usually implicitly -when describing any myo-inositol phosphate.] The separate purification and characterization of both the Ins(1,3,4)P 3 and Ins(3,4,5,6)P 4 kinase activities led to the discovery that each enzyme was strongly inhibited by the other's substrates [79, 80] . These observations raised the possibility that both activities might be performed by enzymes that are, at the very least, highly similar. Majerus' laboratory cloned the human Ins(1,3,4)P 3 6-kinase in 1996 [81] . Subsequently, we [82] independently obtained a human brain kinase cDNA as an EST (expressed sequence tag) clone, expressed recombinant protein in Escherichia coli, and we showed that this single 46 kDa enzyme catalysed both Ins(1,3,4)P 3 5/6-kinase and Ins(3,4,5,6)P 4 1-kinase activities. This catalytic versatility is physiologically relevant in vivo (see below).
Kinase mRNA transcripts are ubiquitous in animal cells, with especially high levels of expression in the brain and the heart [81] . It is possible that different mRNA transcripts might be formed by alternative splicing of the 5 non-translated region [82] . There appears to be only one isoform of this kinase expressed in mammalian cells (Genbank NP 055031). Alignments with genomic sequence (Genbank NT 026437) indicate that the mRNA transcript arises from 12 exons on chromosome 14. [Unfortunately, the HUGO-approved name for this gene is ITPK1 (inositol trisphosphate kinase), which predates the discovery of its multiple catalytic activities and misleadingly implies similarities with ITPKa, ITPKb and ITPKc, the very different genes for the Ins(1,4,5)P 3 3-kinase family.]
This Ins(1,3,4)P 3 kinase/Ins(3,4,5,6)P 4 kinase is widely distributed across the phylogenetic spectrum. For example, there are apparent homologues in the mouse (GenBank NM 172584; 94 % identical with human) and Xenopus (BC054977; 78 % identity). Surprisingly, in view of its relatively small genome, the mustard weed Arabidopsis appears to possess three homologues (AY050408, AY096412 and AY096566; 16-29 % identity). Entamoeba histolytica, a tissue-lysing amoeboid pathogen, also reportedly contains a homologue, but this enzyme is atypical in that it also phosphorylates Ins(1,4,5)P 3 [83] . Actually, a broader aspect of the inositol phosphate enzymology of this organism is atypical, in that it has apparently adapted to the synthesis of large quantities of neo-inositol phosphates instead of the more familiar c 2004 Biochemical Society myo-inositol-based family [84] . Yeasts apparently do not have the Ins(1,3,4)P 3 kinase/Ins(3,4,5,6)P 4 kinase.
Biological significance of Ins(3,4,5,6)P 4
The kinase that phosphorylates Ins(3,4,5,6)P 4 is of particular biological interest, because Ins(3,4,5,6)P 4 is an intracellular signalling molecule. For example, Ins(3,4,5,6)P 4 inhibits conductance of those Cl − channels in the plasma membrane that are activated by Ca 2+ and CaMKII (calmodulin-dependent protein kinase II) [85] [86] [87] . This forms part of the process by which salt and fluid secretion is regulated in the lungs, exocrine glands and gastrointestinal tract [88] . The effects of Ins(3,4,5,6)P 4 are likely to be more farreaching. For example, Ca 2+ -activated Cl − channels also regulate neurotransmission [89] and smooth muscle contraction [90] , both of which should be considered as potential Ins(3,4,5,6)P 4 targets. Ins(3,4,5,6)P 4 is probably also an important signal in plants; the polyphosphate modulates pollen tube growth through an effect upon Cl − channels [91] . Ins(3,4,5,6)P 4 regulates the conductance of at least one other type of Cl − channel -a ClC channel in insulin-secreting granules inside pancreatic β-cells [92] . ClC provides charge-shunt neutralization to support a functionally important acidification of the granules by H + -ATPase [92, 93] . This is a general process that controls acidification of various types of intracellular vesicles [94] . The ATP-driven delivery of H + into the vesicle interior is electrogenic, and if this were not charge-compensated, a large transmembrane electrical gradient would develop. This would provide an electrochemical impediment to further H + pumping, even before a substantial acidification of the vesicular interior could take place [94] [95] [96] . Cl − flux into the vesicles, through ClC, provides the electrical neutralization that is necessary to prevent an inhibitory electrochemical gradient from forming [94] [95] [96] . It has been proposed that intraluminal acidification drives the priming of insulin granules, so that they become competent to fuse with the plasma membrane and release their cargo [93] . In support of this idea, we showed that Ins(3,4,5,6)P 4 reduces insulin secretion by decreasing the degree of ClC-dependent acidification of insulin granules [92] .
There are many ClC family members [97] . Antibodies against the type 3 ClC protein have disclosed its association with insulin granules [93] , although other ClC channels could also be present. So it is not clear which particular ClC proteins are regulated by Ins(3,4,5,6)P 4 . Further work will also be needed in order to determine whether Ins(3,4,5,6)P 4 regulates ClC-dependent acidification of additional intracellular vesicles, the roles of which include endocytosis, enzyme targeting, H + -coupled uptake of small molecules (such as neurotransmitters), and optimization of the proteolytic activities of, for example, prohormone processing enzymes [94] .
The action of Ins(3,4,5,6)P 4 upon Cl − channels can be viewed as being dynamic in nature. The open probability for individual channels will be determined from a dynamic integration of separate inputs that are either inhibitory [e.g. Ins(3,4,5,6)P 4 ] or stimulatory (e.g. CaMKII). The strength of input from Ins(3,4,5,6)P 4 can be varied in both a temporal and a spatial fashion by virtue of localized changes in its concentration. In addition, the efficacy of Ins(3,4,5,6)P 4 decreases as the intracellular Ca 2+ concentration rises [98] or when protein phosphatase activities are reduced [98, 99] . By regulating the number of Cl − channels in a single cell that are open at any instant, the whole-cell Cl − current can be manipulated in a quantitative rheostatic manner. Localized changes in the strength of competing inhibitory and stimulatory inputs may also be co-ordinated reciprocally. That is, an increase in CaMKII activity may accompany a decrease in Ins(3,4,5,6)P 4 concentration; the overall effect of such integrative signalling would be to amplify the signal output [100] . One of the key players in this protein-based computational circuitry is the reversible kinase/phosphatase that establishes the prevailing cellular concentration of Ins(3,4,5,6)P 4 (see below).
There is one very important aspect of Ins(3,4,5,6)P 4 that we do not yet understand, namely its mechanism of action. It has been argued that Ins(3,4,5,6)P 4 acts as a channel blocker, since its effects upon a recombinant Cl − channel could be observed ". . . in an [experimental] system devoid of additional intracellular signalling components" [101] . It is argued here that the latter interpretation is not correct. The cloned Cl − channel in question was expressed in Xenopus oocytes, but only at low levels, and it was membrane fragments (not purified recombinant protein) that were extracted from the oocytes and incorporated into lipid bilayers in order to study the action of Ins(3,4,5,6)P 4 [101] ; many ancillary membrane-associated proteins can safely be assumed to have contaminated the experiments. Therefore those experiments do not exclude Ins(3,4,5,6)P 4 acting indirectly upon Cl − channels through intermediary proteins. Indeed, we have shown that the action of Ins(3,4,5,6)P 4 upon epithelial Cl − channels depends upon a very important class of signalling proteins, namely protein phosphatases [98, 99] . Single-channel recordings also directly demonstrated that Ins(3,4,5,6)P 4 is not a channel blocker [98] .
Significance of the catalytic versatility of the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase
One important function of the Ins(1,3,4)P 3 6-kinase activity is to supply precursor material for the synthesis of Ins(1,3,4,5,6)P 5 , InsP 6 and the diphosphorylated inositol phosphates (Scheme 1). In mammals this kinase is absolutely essential to this anabolic process; there are no other known pathways that synthesize these highly phosphorylated metabolites. However, plants [102] and slime moulds [103] have active alternative synthetic routes. Indeed, the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase seems to make only a minor contribution to InsP 6 synthesis in maize, since when the kinase gene is compromised, InsP 6 levels fall by only 30 % [104] . Yeasts use these alternative synthetic routes exclusively; they do not contain any Ins(1,3,4)P 3 6-kinase activity.
Another function of the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase is to control the signalling strength of the Ins(3,4,5,6)P 4 messenger. A key aspect of this control process is the reversibility of the kinase. That is, the enzyme also acts as an Ins(1,3,4,5,6)P 5 1-phosphatase [105] . The phosphate group that is removed from Ins(1,3,4,5,6)P 5 need not be released into the bulk phase, and instead it seems that the phosphate can be retained by the enzyme and offered to either Ins(3,4,5,6)P 4 or Ins(1,3,4)P 3 [105] . Elevations in the levels of Ins(1,3,4)P 3 will therefore competitively inhibit Ins(3,4,5,6)P 4 phosphorylation and, by promoting the dephophorylation of the putative phosphoryl-enzyme intermediate, Ins(1,3,4)P 3 augments Ins(1,3,4,5,6)P 5 dephosphorylation [105] . Thus the addition to cells of a cell-permeant analogue of Ins(1,3,4)P 3 led to a specific increase in the cellular levels of Ins(3,4,5,6)P 4 [106] . This is an important point because, in vivo, the cellular levels of Ins(1,3,4)P 3 increase by mass-action effects whenever Ins(1,4,5)P 3 synthesis is activated (see Scheme 1) following receptor-dependent phospholipase-C-mediated hydrolysis of PtdIns(4,5)P 2 [107] . Thus receptor-activated increases in cellular Ins(1,3,4)P 3 levels are inevitably coupled to increases in Ins(3,4,5,6)P 4 levels.
We demonstrated that the enzyme operates as an Ins(1,3,4,5,6)P 5 1-phosphatase in vivo by stably transfecting T 84 cells with the gene for the human enzyme. This did not affect 'resting' levels of Ins(3,4,5,6)P 4 , presumably because both Ins(3,4,5,6)P 4 1-kinase and Ins (1,3,4 ,5,6)P 5 1-phosphatase activities were elevated to the same extent [105] . However, during receptor activation, the accumulation of Ins(1,3,4)P 3 inhibits the Ins(3,4,5,6)P 4 1-kinase and stimulates the Ins(1,3,4,5,6)P 5 1-phosphatase (see above). This shift in the dynamic balance between phosphatase and kinase activities leads to a proportionately greater overexpression of the phosphatase activity in receptor-activated cells. Thus the enzyme-transfected T 84 cells show amplified receptor-dependent increases in Ins(3,4,5,6)P 4 levels, relative to vector-transfected cells [105] . These experiments confirm that control over the expression of the reversible kinase/phosphatase can regulate Ins(3,4,5,6)P 4 signalling. These studies also show that the strength and duration of the Ins(3,4,5,6)P 4 signal is inevitably tied to the degree and duration of receptor-dependent phospholipase C activation. This is clearly a situation where promiscuous catalytic activity of an inositol phosphate kinase is biologically important in regulating signal transduction. The structure of this enzyme is not yet known. Indeed, the amino acid residues that contribute to the catalytic site of this enzyme have not even been identified, in no small part because the enzyme has no major sequence similarities with any other inositol phosphate kinases. However, the K m values for either Ins(3,4,5,6)P 4 and Ins(1,3,4)P 3 as substrate (0.1-0.5 µM) are identical with the K i values determined when each substrate inhibits phosphorylation of the other [79, 82, 106, 108] . It is thus a reasonable assumption that the enzyme uses a single catalytic site to perform all of its inositol phosphate kinase activities. We can therefore rationalize the enzyme's promiscuous catalytic activity ( Figure 5 ) using some of the same principles that we apply to the inositol phosphate kinase activities of Ipmk (Figure 4 ). Thus we [98] recently proposed a model in which substrates can bind to the active site of the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase in three different orientations ( Figure 5) . The model offers two modes of Ins(1,3,4)P 3 and Ins(1,2,4)P 3 binding, to explain why both substrates are phosphorylated at the 5-hydroxy and 6-hydroxy groups [80] [81] [82] 109] . Finally, Figure 5 accounts for the ability of the kinase to phosphorylate the 1-hydroxy group of Ins(3,4,6)P 3 [105] , a non-physiological substrate (in mammals at least).
In Figure 5 , groups attached to the inositol ring that are coloured red have a common nature and orientation in all three binding modes; these are likely to be the most important of the groups designating substrate recognition. Yet, by themselves, these groups provide insufficient ligand recognition elements, because they are all present in Ins(1,4)P 2 , which is not a substrate [105] . Thus, as with Ipmk (Figure 4) , it is proposed that each binding mode utilizes different sets of substrate recognition motifs in a combinatorial manner. Further support for this combinatorial recognition hypothesis comes from the following observation. The enzyme apparently has a preference for binding Ins(1,3,4)P 3 in mode 2 (since it is phosphorylated predominantly at the 6-hydroxy group [81, 82] ). In contrast, mode 3 binding is preferred for Ins(1,2,4)P 3 (it is phosphorylated predominantly at the 5-hydroxy group [109] ). These different substrate-binding preferences must be dictated by the phosphate and hydroxy groups at the 2-and 3-positions of Ins(1,3,4)P 3 and Ins(1,2,4)P 3 , even though these groups are only conserved in one (coloured green in Figure 5 ) or two (coloured purple) of the three modes. As with Ipmk (see above), an active site that utilizes both flexible and rigid regions [4] would seem to be particularly well suited to this combinatorial model for ligand recognition. Further structural and mutagenic work will hopefully clarify this hypothesis. The diagram shows three proposed substrate-binding modes utilized by the Ins(1,3,4)P 3 / Ins(3,4,5,6)P 4 kinase, as originally outlined in [105] . Note where the inositol ring has been rotated through vertical and/or horizontal planes in order to align equivalent recognition motifs. Groups that are coloured red are common to all three binding modes and are proposed to be essential for high-affinity ligand recognition. The site of phosphorylation is indicated by a yellow circle. Groups coloured purple are common to two binding modes and are considered most likely to play a mode-specific role in substrate recognition. Groups coloured green are deemed least important to substrate recognition, as their position is common to only one binding mode.
Protein kinase activity: additional catalytic versatility?
Predictive modelling studies have led to the suggestion that the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase may have a structure similar to that exhibited by the 'ATP-grasp' family of protein kinases, in which ATP is held between two antiparallel β-sheets [110] . This comparison suggests that there is a relatively close evolutionary link between protein kinases and the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase. One group [111, 112] has suggested that there is also a functional similarity. Both the native kinase purified from bovine brain and the baculovirus-expressed recombinant human kinase have been reported to phosphorylate Ser and Thr residues on several transcription factors [ATF-2 (activating transcription factor-2), c-jun, IκBα and p53], at least in vitro [111, 112] . So far, there is no evidence that, in vivo, the Ins(3,4,5,6)P 4 /Ins(1,3,4)P 3 kinase can either phosphorylate any of these proteins or affect their transcriptional functions. In the specific case of IκBα, both its nuclear translocation and its transcriptional activity remained unmodified following overexpression of the Ins(1,3,4)P 3 / Ins(3,4,5,6)P 4 kinase in HEK cells [113] . The recombinant Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase can phosphorylate itself in vitro [112] , but this observation in itself does not shed light on whether or not the enzyme has protein kinase activity in vivo; many ATP-binding proteins that are not protein kinases still undergo autophosphorylation [114] . For a kinase of this size, and considering the modelling prediction of a single ATP-binding site [110] , it could be anticipated that the inositol phosphate kinase and protein kinase catalytic sites would overlap. However, it was reported that protein kinase activity was unaffected by Ins(3,4,5,6)P 4 [112] . Thus there is as yet no suggestion that inositol phosphates might modulate this protein kinase activity, and the significance of this proposed multifunctionality remains unclear at present.
Majerus and colleagues [111] have presented evidence that the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase associates with COP9 during its purification from bovine brain. COP9 is a key player in the acronym-heavy ubiquitination field. The COP9 multimeric signalosome (SCN) regulates the activity of SCF-type E3 ubiquitin ligases [115, 116] ; SCF itself comprises four subunits: an SKP1 (S-phase kinase-associated protein 1)-like protein, a 'cullin' protein, a so-called 'F-box protein' (FBP) and an Rbx1/Hrt1/Roc1 subunit [116] . 'Neddylation' (i.e. attachment of the Nedd8 protein) to cullin stimulates the ability of SCF to ubiquitinate proteins, thereby targeting them for proteolytic destruction. Since COP9 deneddylates the cullins, the entire complex can downregulate the activities of cullin-based ligases [115] . While biochemical evidence supports this notion, genetic data indicate that COP9 is also a positive regulator of cullin function [115] . There is still further evidence that a protein kinase activity co-purifies with native COP9; this kinase has been reported to phosphorylate certain transcription factors -including p53 and IκBα -thereby targeting them for ubiquitination-initiated degradation [117, 118] . Majerus and colleagues [111] proposed that this protein kinase activity in COP9 was catalysed by the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase. However, Dubiel's group [117] have purified the COP9 complex from human erythrocytes in such a way that all of the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase activity was removed, yet protein kinase activity was retained, and attributed to protein kinase D and casein kinase [117] . The absence of inositol phosphate kinase activity was determined by Western blotting [117] and by enzyme assays (S. B. Shears and W. Dubiel, unpublished work). The latter observations dispute the idea that the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase is "the COP9-associated kinase", as suggested by Majerus' laboratory [111] . On the other hand, an association of the kinase with COP9 in vitro may yet prove to be more than coincidental. Many proteins do bind to COP9, so it has been suggested that the signalosome acts as a scaffold, not just for the constituents of the proteolytic process, but also for some of the doomed substrates [116] . Perhaps the cellular levels of Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase are regulated by COP9. In fact, experiments with adrenal glomerulosa cells performed some years ago [119] suggest that the levels of cellular Ins(1,3,4)P 3 6-kinase activity might be controlled by a cAMP-mediated, phosphorylation-dependent process. Other more direct protein-protein interactions of COP9 with the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase may also influence its activity [111] . We do not know of any other regulatory processes that might modulate Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase activity. For example, it is not affected by either Ca 2+ (plus or minus calmodulin or CaMKII), protein kinase A or protein kinase C ( [79] ; X. Yang and S. B. Shears, unpublished work).
Overexpression of the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase in HEK cells has recently been reported to protect against TNFα (tumour necrosis factor α)-induced apoptosis [113] . Conversely, reduced expression of the kinase by RNAi (RNA interference) increased the susceptibility of HeLa cells to TNFα-induced apoptosis [113] . However, changes in the levels of expression of this kinase can have a multitude of effects. The Ins(1,3,4)P 3 / Ins(3,4,5,6)P 4 kinase is a central player in the pathway of synthesis of many highly phosphorylated inositol phosphates (Scheme 1), any of which might be responsible for the modified sensitivity to apoptosis. Thus the study of Sun et al. [113] does not yet constitute evidence for multifunctionality of the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase itself.
DIPHOSPHOINOSITOL POLYPHOSPHATE KINASES
Discovery and characteristics
Two independent reports in 1993 described enzyme activities in cell lysates that converted Ins(1,3,4,5,6)P 5 and InsP 6 into diphosphorylated inositol phosphates [120, 121] . Since then, much of what we have since learnt about the proteins that synthesize these diphosphates has come from the work of Snyder, Saiardi and their colleagues. Three isoforms of these kinases, ranging in size from 46 to 49 kDa, have been cloned from animals [16, 122, 123] . Homologues in yeast (120 kDa; [16] ) and Dictyostelium (72 kDa; [124] ) have also been identified. All of these kinases share two important features with Ipmk (Figure 2 ), namely the PxxxDxKxG catalytic domain, and a remote, catalytically essential Ser-SerLeu-Leu (or similar; see Figure 2 ) tetrapeptide. Yeast and Dictyostelium each possess only one isoform of InsP 6 kinase, so disruption of the corresponding gene reduces the synthesis of diphosphoinositol polyphosphates nearly completely [60, 124, 125] . There is an under-appreciated point that emerges from these experiments. In spite of being InsP 6 kinase null, and even though these cells contain active phosphohydrolase activities towards the diphosphoinositol polyphosphates [126] , they nevertheless retain small steady-state amounts of these diphosphates [60, 61, 124] . What might be the source of the remaining synthetic activity? Are such data a warning that it might be premature to dismiss as non-physiological the diphosphoinositol polyphosphate synthase activity of Ipmk (see above)? Alternatively, it has been reported that the 'PP-InsP 5 kinase' in Dictyostelium can phosphorylate InsP 6 [84] . Perhaps the still uncloned PP-InsP 5 kinase from yeast and other organisms (see Scheme 1 and [127, 128] ) might also utilize InsP 6 as a substrate.
The yeast InsP 6 kinase (Kcs1) is endowed with two leucine zipper motifs. These are amphipathic heptad repeats [(LxxxxxxL) n , where the value of n is typically 4 or 5] which form coiled-coil structures that dimerize; leucine zippers are found in proteins that regulate transcription [129] . Indeed, there is evidence that the yeast InsP 6 kinase activity does influence gene expression (see above and [54] ). These leucine-based heptad repeats are not conserved in the mammalian InsP 6 kinases, but there is indirect evidence that these enzymes may still have a nuclear function. When the type 2 InsP 6 kinase was overexpressed in HEK cells as a fusion construct with green fluorescent protein, it was concentrated predominantly in the nucleus, although the protein does not yet have a recognized nuclear localization signal [122] ; in similar experiments, the type 1 and 3 kinases were expressed in both the nucleus and the cytosol [122] .
The InsP 6 kinase in Dictyostelium is activated when the free-living amoeboid form of this organism exhausts its food supply and aggregates into a multicellular organism; in the hours immediately following starvation, the cellular levels of PP-InsP 5 increase 10-fold [130] through the actions of the Gprotein-coupled cAMP receptor [124] . This apparently regulates chemotaxis (see below). Release of Ca 2+ from the endoplasmic reticulum inhibits cellular InsP 6 kinase activity [131] , but the underlying mechanisms have not been elucidated. There is little other information concerning how the activities of the InsP 6 kinases are regulated by the cell.
Catalytic versatility
The mammalian type 1 and 3 kinases phosphorylate Ins(1,3,4,5,6)P 5 and InsP 6 with nearly equal affinities and similar V max values [60, 122] . Thus the type 1 and 3 kinases appear to be indifferent to the presence or absence of a 2-phosphate on the inositol ring. Despite this substrate versatility, the enzymes are almost universally known as 'InsP 6 kinases'. (It has been suggested that these enzymes might be more appropriately named 'diphosphoinositol polyphosphate synthases' [132] ; this idea has been met with a degree of enthusiasm that might benevolently be described as underwhelming.) The fact that both Ins (1,3,4 ,5,6)P 5 and InsP 6 are physiologically significant substrates in vivo can be shown by perturbing the dynamic equilibrium of the kinase/ phosphatase substrate cycles in which they participate (see Scheme 1). This can be achieved simply by adding fluoride to intact cells to inhibit the diphosphoinositol polyphosphate phosphohydrolases [133] , exposing the underlying activities of the kinases. Cellular levels of both PP-InsP 4 and PP-InsP 5 increase substantially, and this is accompanied by decreases in the levels of the Ins(1,3,4,5,6)P 5 and InsP 6 precursors [120, 134] . On the other hand, the type 2 kinase is less versatile; it is kinetically more specialized to metabolize InsP 6 {the affinity for which is 20-fold greater than that for Ins(1,3,4,5,6)P 5 ; [60] }.
The physiological significance of the kinases that fabricate diphosphate derivatives from both Ins(1,3,4,5,6)P 5 and InsP 6 is unclear. At least in Sacch. cerevisiae, the two diphosphates in question, PP-InsP 4 and PP-InsP 5 respectively (Figure 3) , have some functional redundancy. This conclusion arises from an analysis of vacuolar biogenesis in cells that lack either the InsP 6 kinase (kcs1 ) or the Ins(1,3,4,5,6)P 5 kinase (ipk1 ). There is fragmented vacuolar morphology in kcs1 cells, in which synthesis of diphosphorylated inositol phosphates is compromised [60] [61] [62] . The ipk1 cells cannot synthesize InsP 6 , and thus they also do not contain any PP-InsP 5 or [PP] 2 -InsP 4 (see Scheme 1) . Yet the ipk1 cells possess normal vacuolar morphology [62] . The explanation for these observations is that the ipk1 cells do still contain active Kcs1, which now compensates for the absence of InsP 6 by instead phosphorylating Ins(1,3,4,5,6)P 5 to PP-InsP 4 (see Scheme 1), and to material tentatively determined (see below) to be [PP] 2 -InsP 3 [62] . Thus Ins(1,3,4,5,6)P 5 di-phosphorylation functionally compensates for loss of InsP 6 di-phosphorylation, as least as far as vacuolar biogenesis is concerned.
The InsP 6 kinases also have the capacity to be reversible under in vitro assay conditions that are physiologically relevant [135] . That is, when purified enzyme is incubated with PP-InsP 5 and ADP, then InsP 6 and ATP are formed [135] . The substrate affinities and V max values for the 'forward' (PP-InsP 5 synthase) and 'reverse' (PP-InsP 5 phosphatase) reactions were determined to be very similar [135] . These data led to the proposal that PPInsP 5 might be a 'high-energy' phosphate donor, but any such role must be very limited, since there is only 1-5 µM PP-InsP 5 in cells [136] . It has also not been possible to demonstrate if kinase reversibility may be significant in vivo. Independently of such a process, cells already have considerable capacity to dephosphorylate PP-InsP 5 through the actions of a family of dedicated phosphatases [133, 137] .
A demonstration that purified recombinant InsP 6 kinase can phosphorylate PP-InsP 5 further, in vitro at least [60] , has inspired speculation that the elusive 'PP-InsP 5 kinase' activity (see Scheme 1) might in fact be catalysed by the InsP 6 kinase in vivo [124] . This idea has to be reconciled with the demonstration that cellular PP-InsP 5 kinase activity can be purified away from all cellular InsP 6 kinase activity ( [128] ; T. Zhang and S. B. Shears, unpublished work). There is also a problem that a maximum of only approx. 5-10 % of added PP-InsP 5 can be phosphorylated by the recombinant InsP 6 kinase, irrespective of the quantity of enzyme in the incubations, or the degree of patience of the experimenter [60] . One possibility is that the InsP 6 kinase might associate with a regulatory protein that switches its reactivity, but if this were the case, both substrate specificity and the positional preference of the kinase would need to be modified.
Another potential complication is that the phosphorylation of PP-InsP 5 by recombinant InsP 6 kinase in vitro might conceivably yield a triphosphate, PPP-InsP 5 , rather than the bisdiphosphoinositol, [PP] 2 -InsP 4 ( Figure 6 ). The latter is certainly a natural product, according to NMR analysis of slime moulds [138] [139] [140] and enzymic assays in mammalian cell lysates [127] . In contrast, it is not known if PPP-InsP 5 is normally present in cells. Equally, the InsP 6 kinases can also add an additional phosphate to PP-InsP 4 [60] . The product was designated [PP] 2 -InsP 3 [60] . However, the possibility has not been excluded that the product might instead be PPP-InsP 4 . Overall, there remain some important unanswered questions concerning the true catalytic versatility of the family of InsP 6 kinases in vivo.
Other roles for the InsP 6 kinases?
Diphosphoinositol polyphosphates represent the most extreme example of the degree to which phosphate groups can be clustered in high density around the inositol ring. Indeed, it is believed that a considerable free-energy change accompanies their dephosphorylation, due to the relief of severe electrostatic and steric constraints within these molecules [121] . This 'high-energy' concept has prompted Snyder's group to study whether diphosphoinositol polyphosphates might phosphorylate proteins directly. However, the results obtained to date are only preliminary and have not yet been published (see [125] ).
Genetic disruption of the turnover of diphosphoinositol polyphosphates has implicated these polyphosphates as being active in several biological arenas. These include effects upon yeast vacuolar biogenesis [60, 62] , endocytosis [62] , stress responses [61] , DNA hyper-recombination [125] and apoptosis [141] . In order to rationalize the diverse nature of these responses, it may be proposed that diphosphoinositol polyphosphates participate in some as yet uncharacterized fundamental regulatory process that is applicable to many biological situations. For example, the polyphosphates might be ligands that modify the functions of certain proteins [16, 135, 142] . In such an event, synthesis and/or metabolism of the polyphosphates can be envisaged to comprise a molecular switch [16, 135, 143] , akin to G-proteins that function as a binary switch between two interconvertible (GTP-bound active and GDP-bound inactive) states. Such a process would provide direct roles for the InsP 6 kinases (and the diphosphoinositol polyphosphate phosphohydrolases) in many biological processes. However, there is only circumstantial evidence in support of this idea. For example, PP-InsP 5 has been found to bind with high affinity to a number of cellular proteins in vitro, including myelin proteolipid protein [144] , coatomer [145, 146] , as well as the clathrin-assembly adaptors AP2 [127] and AP3/AP180 [62, 147] . Unfortunately, as pointed out previously [143] , the physiological relevance of these in vitro binding assays remains unclear. Typically, such experiments have been conducted in the absence of bivalent cations, which normally neutralize some of the polyphosphate's high negative charge density. Non-specific unphysiological interactions between PP-InsP 5 and proteins are more likely when bivalent cations are absent.
A recent report [124] does provide a more convincing demonstration of PP-InsP 5 being a regulatory ligand, in this case by binding to Crac (cytosolic regulator of adenylate cyclase) in the slime mould, D. discoideum. PP-InsP 5 competed with PtdIns(3,4,5)P 3 for binding to the pleckstrin homology domain of Crac, and this phenomenon appeared to influence chemotaxis [124] . Whether PP-InsP 5 is a physiologically relevant competitor for PtdIns(3,4,5)P 3 binding proteins in other organisms remains to be seen. The slime moulds are unusually suited to this ligand competition, as they contain concentrations of diphosphoinositol polyphosphates in excess of 100 µM [130, 138] . The only other organisms known to have such high levels of these compounds are the pathogen Entamoeba histolytica and the free-living Phreatamoeba balamuthi [84] . In contrast, yeasts and mammalian cells contain only 1-5 µM PP-InsP 5 [74, 136] , so competition with PtdIns(3,4,5)P 3 will be less likely in those organisms.
A specific role for type 1 mammalian InsP 6 kinase emerged from a study that identified a new guanine nucleotide exchange factor for Rab3a, named GRAB. The neuron-specific Rab3a is one of over 40 mammalian Rabs, which regulate vesicle trafficking processes and are members of the Ras superfamily of small GTPases [148] . It was found that the ability of GRAB to promote GDP release from Rab3A was reduced in cells in which the type 1 mammalian InsP 6 kinase was overexpressed [149] . This seemed to result from competition between the kinase and Rab3a for binding to GRAB [149] . This effect was independent of the kinase catalytic domain, since a catalytically inactive mutant of the type 1 kinase was equally effective [149] . Thus there is no evidence that this effect is tied to the turnover of inositol phosphates. Finally, a recent study, using DNA microarrays and Northern analysis, identified 30 genes in Sacch. cerevisiae whose expression was influenced by the InsP 6 kinase [54] . Of course, it will be useful to follow up these microarray experiments with studies that separate direct primary effects of the kinase from secondary indirect events.
CONCLUSIONS
In this review, the case has been made that certain inositol phosphate kinases do indeed have versatile catalytic domains that can metabolize a range of inositol phosphate substrates in vivo. A new combinatorial ligand recognition hypothesis is put forward in order to explain this versatility. Sometimes it is clear that this metabolic promiscuity has been exploited to facilitate tight regulation of physiological processes. Such multifunctionality can add to the complexity with which signal transduction pathways interact. The latter point is best illustrated by the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase. However, there are other cases where it is still unclear what the significance might be of a kinase (e.g. the 'InsP 6 kinase') phosphorylating two or more inositol phosphates. The proposed significance of the protein kinase activity of the Ins(1,3,4)P 3 /Ins(3,4,5,6)P 4 kinase also needs further exploration. As for the postulated 'moonlighting' [1] roles of transcriptional regulation by Ipmk, the function of the acidic transcriptionally active domains in Ipmk from certain yeasts has a solid basis in 20 years of research. More recent work that focuses on transcriptional functions for the kinase activity of Ipmk is less well developed. It seems fair to conclude that the proposed role of the kinase catalytic domain in the regulation of argininemetabolizing genes in yeast is still controversial. Nevertheless, the hypothesis still survives, in the more recent guise of the regulation of phosphate-responsive genes. In any case, it seems that our appreciation of the versatility of inositol phosphate kinases is likely to increase, as further work pursues some of the ideas and questions outlined in this review.
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